Roger Susi: Well, it’s just pretty — I mean it’s just very steady. So yes, we’re not seeing — if your question is, are we seeing cost impacts, those plastic devices of PVC and polycarbonate and such. There have been increases in that sort of — in those commodities, but it hasn’t reflected by the time we mold those parts and turn them into what we turn them into, there’s still pennies in the cost of the IV sets. So we don’t see any — we haven’t had any negative impacts to the cost structure in the disposables.
Unidentified Analyst: Okay. And given on the inflation and supply issues and all can we assume that you guys have been reasonably able to pass on those price increases of the inputs to your customers?
Roger Susi: Short answer is yes. We did that rather early, I guess, and the COVID hit. We started getting hit; this is year-and-a-half ago, at least six, seven quarters ago. We started seeing the component issues, electronic components and whatnot primarily, really, really giving us heartburn. And we were able to negotiate increase the prices for these key products, the pump and the monitor. Some of that — because of the contracts and how long they take, some of those have become effective already. And some of them, though we negotiated them over a year ago, you’ll be — they’re yet to come — become effective still in these next six months. So yes, we’ve had price increases. Some have taken place and are reflected in our earnings and some have been negotiated in and aren’t actually physically accountable for yet, but will be over the next two quarters.
Unidentified Analyst: Great. And to an extent you can share with us the dynamic of disposable per device. I’m sure you track a rough color you can give how that is trending. That would be very helpful.
Roger Susi: Maybe you can jump in on that one, Jack.
Jack Glenn: I’m not sure if I visit on as far as the trend on the disposables.
Roger Susi: I guess sales of the disposable trend.
Unidentified Analyst: So essentially, like one way to look at your revenue model is, there is a disposable revenue stream and there is devices. And you know, I know you don’t divide it up by units, but if you can — and maybe if you guys track it, disposables per device? Or any color you can give, which can give us some understanding on how it is trending? Like maybe more disposables are going out per device or less? Or it is mostly on the price, something if you can give us a color on that.
Jack Glenn: Yes. I think — well, I think Roger touched on some of this earlier when we look at the disposables and certainly, the growth there is correlating with the growth in both the pumps and the monitors. As a percentage of our sales, I think it’s — total sales has gone range somewhere around 20%, 25%, this last quarter, I think it was around 30%. So it is has shown some growth. But I think it’s probably going to stay within that same range as a percentage of sales going forward, and again correlates pretty closely with our growth on the devices.
Unidentified Analyst: Perfect.
Roger Susi: I might add, IRadimed is a little bit different, though, we have a disposable that’s a nice piece of revenue and it has a nice margin, unlike a lot of companies, they may build their business model around the disposable and offer the thing that uses the disposable, the razor, if you will, at not so great a margin. If you delve into our margins at that detail, these gross margins that we talked about a few minutes ago, these are the same, whether it’s the device or the disposable. So I mean, that should tell you a lot more about our model. It’s not quite maybe typical in that regard.
